53. Sjogren syndrome Clinical trials / Disease details
Clinical trials : 283 / Drugs : 320 - (DrugBank : 101) / Drug target genes : 56 - Drug target pathways : 181
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04615455 (ClinicalTrials.gov) | November 3, 2020 | 3/11/2020 | Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's Syndrome | A Randomized Clinical Trial Evaluating Allogeneic Adipose-derived MesenchymAl Stem Cells as a Treatment of Dry Eye Disease in Patients With Sjögren's Syndrome | Keratoconjunctivitis Sicca, in Sjogren's Syndrome | Drug: ASCs;Drug: Cryostor CS10 | Rigshospitalet, Denmark | NULL | Active, not recruiting | 18 Years | N/A | All | 40 | Phase 2 | Denmark |